✦ LIBER ✦

Mo1407 Serum CA 19-9 Is a Powerful Discriminator of Pancreatic Adenocarcinoma in Patients Referred for ERCP or EUS With Suspected Pancreatic Cancer

✍ Scribed by Kwon, Richard S.; Choksi, Neel; Scheiman, James M.; Piraka, Cyrus R.; Elta, Grace H.; Elmunzer, B. Joseph; Young, Benjamin E.; Prabhu, Anoop; Wamsteker, Erik-Jan; Harthun, Kenneth G.; Brenner, Dean E.; Anderson, Michelle A.

Book ID: 122139824
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 171 KB
Volume: 144
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(13)62438-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mo1530 Utility of Serum CA19-9 in the De

Mo1530 Utility of Serum CA19-9 in the Detection of Pancreatic Ductal Adenocarcinoma (PDAC) Among EUS-Referred Patients: the Clinical Features of Patients With Pdac With Normal CA 19-9

✍ Parikh, Dhavan A.; Azarm, Ali; Urayama, Shiro 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 81 KB

Elevated Serum Carcinoembryonic Antigen

Elevated Serum Carcinoembryonic Antigen 19-9 (CA 19-9) Levels Are Highly Specific for Malignancy in Patients Referred for Endoscopic Ultrasound (EUS) With Suspected Pancreatic Cancer but Without a Tissue Diagnosis

✍ Anderson, Michelle A. ;Sheth, Neil M. ;Scheiman, James ;Plonka, Caitlyn M. ;Zhu, 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 67 KB